Lipocine Provides New Regulatory Update on TLANDO™ ...Middle East

PR Newswire - News
Lipocine Provides New Regulatory Update on TLANDO™
SALT LAKE CITY, Dec. 4, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration ("FDA") has informed the Company that it is continuing to work...

Hence then, the article about lipocine provides new regulatory update on tlando was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lipocine Provides New Regulatory Update on TLANDO™ )

Apple Storegoogle play

Last updated :

Also on site :



Latest News